3D model is for representation purpose only.
.
.
![]()  | 
                         ![]()  | 
                         ![]()  | 
                         ![]()  | 
                         ![]()  | 
                    
                        
|---|---|---|---|---|
| RRLSYSRRRF | succinic acid | 2-pyrrolinodoxorubicin | 
| Identification | |
|---|---|
| ConjuPepDB ID |   cpd01387  | 
| Smiles | |
| Molecular weight |   2072.02  | 
| Molecular formula |   C95H137N27O26  | 
| Chemical name | Peptide information | 
| Sequence (one letter) |   RRLSYSRRRF  | 
| Length |   10  | 
| Peptide name |   N/A  | 
| External ID | |
|---|---|
| CAS number |   757967-33-2  | 
| Other information | |
|---|---|
| Application |   Anticancer therapy  | 
| Additional function |   enhance cellular uptake and overcome multidrug resistance  | 
| Pharmacological class |   anticancer  | 
| Conjugate type |   amide  | 
| Linker |   N/A  | 
| Linker Type |   succinic acid  | 
| Small molecule |   2-pyrrolinodoxorubicin  | 
| Small molecule CAS |   175795-76-3  | 
| Structure method |   HPLC, LC/MS/MS  | 
| Calculated properties | |
|---|---|
| LogP |   -6.47313  | 
| Rotatable bonds |   59  | 
| H bond donor |   33  | 
| H bond acceptor |   41  | 
| Polar surface area (PSA) |   893.64000  | 
| Citations | |||||
|---|---|---|---|---|---|
| ID | Title | Year | Authors | Journal | DOI | 
2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance  | 2004  | Castex, Cedric; Merida, Peggy; Blanc, Emmanuelle; Clair, Philippe; Rees, Anthony R.; Temsamani, Jamal  | Anti-Cancer Drugs  | ||